文献速递腹部CT

CT对多药诱导化疗后局部进展期胰腺癌手术可切除性的预测价值:NEOLAP-AIO-PAK-0113前瞻性多中心2期试验结果

Predictive value of computed tomography on surgical resectability in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: Results from a prospective, multicentre phase 2 trial (NEOLAP-AIO-PAK-0113).
PubMed 文献 · Eur J Radiol · 2023-04-10

本研究基于前瞻性多中心随机2期NEOLAP试验,评估当前基于影像的可切除性标准及影像学缩瘤程度对多药诱导化疗后局部进展期胰腺癌手术可切除性的预测价值。83例患者可评估中心复核的基线与再分期影像,中心复核降期罕见(7.7%),但肿瘤缩小常见(任何缩小90.4%,RECIST部分缓解26.5%)。任何缩小预测R0切除的敏感度为97%,阴性预测值为0.88;ROC分析显示肿瘤缩小是R0切除的预测因素(AUC 0.647,p=0.028),最佳截断值为缩小22.5%,敏感度65%,特异度61%。结论:基于影像的肿瘤缩小而非降期可指导筛选多药诱导化疗后局部进展期胰腺癌中有现实R0切除机会的患者。

要点

  • 中心复核降期罕见(7.7%),肿瘤缩小常见(任何缩小90.4%)。
  • 任何缩小预测R0切除敏感度97%,阴性预测值0.88。
  • 肿瘤缩小预测R0切除AUC 0.647,最佳截断值缩小22.5%。

局限性

  • 中心复核降期罕见(7.7%),降期标准在此人群中的预测价值有限。
  • 任何缩小与RECIST部分缓解患者的R0切除率无显著差异(37.3% vs 40.9%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess the role of current imaging-based resectability criteria and the degree of radiological downsizing in locally advanced pancreatic adenocarcinoma (LAPC) after multiagent induction chemotherapy (ICT) in multicentre, open-label, randomized phase 2 trial.

METHOD: LAPC patients were prospectively treated with multiagent ICT followed by surgical exploration within the NEOLAP trial. All patients underwent CT scan at baseline and after ICT to assess resectability status according to national comprehensive cancer network guidelines (NCCN) criteria and response evaluation criteria in solid tumors (RECIST) at the local study center and retrospectively in a central review. Imaging results were compared in terms of local and central staging, downsizing and pathological resection status.

RESULTS: 83 patients were evaluable for central review of baseline and restaging imaging results. Downstaging by central review was rarely seen after multiagent ICT (7.7%), whereas tumor downsizing was documented frequently (any downsizing 90.4%, downsizing to partial response (PR) according to RECIST: 26.5%). Patients with any downsizing showed no significant different R0 resection rate (37.3%) as patients that fulfilled the criteria of PR (40.9%). The sensitivity of any downsizing for predicting R0 resection was 97% with a negative predictive value (NPV) of 0.88. ROC-analysis revealed that tumor downsizing was a predictor of R0 resection (AUC 0.647, p = 0.028) with a best cut-off value of 22.5% downsizing yielding a sensitivity of 65% and a specificity of 61%.

CONCLUSIONS: Imaging-based tumor downsizing and not downstaging can guide the selection of patients with a realistic chance of R0-resection in LAPC after multi-agent ICT.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Guggenberger, Bley, Held, et al. Predictive value of computed tomography on surgical resectability in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: Results from a prospective, multicentre phase 2 trial (NEOLAP-AIO-PAK-0113). Eur J Radiol. 2023. PMID: 37080059. doi:10.1016/j.ejrad.2023.110834

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。